SearcharxivSearch

arXiv subjects

Anai N. Kothari

Publications and source records attributed to Anai N. Kothari.

4 recordsLinked to original sources

Model Retirement Creates Reproducibility Risk in Biomedical AI Publications

Background. Large language models (LLMs) are being adopted in biomedical research at a rapid and accelerating pace, yet commercial services that host many widely used models operate under deprecation schedules that can complicate scientific reproducibility. Methods. We searched PubMed for original research articles from 2022 through March 2026 that applied a specific LLM to a biomedical task. An extraction agent identified model names from 61,077 article abstracts with human reviewers validating a subset for extraction accuracy. Extracted model names were normalized to canonical model identifiers. Lifecycle data (release date, retirement date, status) were compiled for the 50 most frequently used models. Results. We identified 8,931 paper-model mentions spanning 5,242 unique publications after restricting the analysis to the 50 most frequently used models. Among these mentions, 77.7% cited a commercial closed-weight model. Overall, 42% involved a model that was already retired by the time of official publication or is scheduled to retire within two years of publication. The median interval from publication to model retirement was 538 days. Conclusion. Many biomedical publications using LLMs are on a trajectory toward computational non-reproducibility after publication. Model deprecation should be treated as a core reporting and preservation issue for biomedical research.

cs.AI

A Novel Algorithm for Personalized Federated Learning: Knowledge Distillation with Weighted Combination Loss

Federated learning (FL) offers a privacy-preserving framework for distributed machine learning, enabling collaborative model training across diverse clients without centralizing sensitive data. However, statistical heterogeneity, characterized by non-independent and identically distributed (non-IID) client data, poses significant challenges, leading to model drift and poor generalization. This paper proposes a novel algorithm, pFedKD-WCL (Personalized Federated Knowledge Distillation with Weighted Combination Loss), which integrates knowledge distillation with bi-level optimization to address non-IID challenges. pFedKD-WCL leverages the current global model as a teacher to guide local models, optimizing both global convergence and local personalization efficiently. We evaluate pFedKD-WCL on the MNIST dataset and a synthetic dataset with non-IID partitioning, using multinomial logistic regression and multilayer perceptron models. Experimental results demonstrate that pFedKD-WCL outperforms state-of-the-art algorithms, including FedAvg, FedProx, Per-FedAvg, and pFedMe, in terms of accuracy and convergence speed.

stat.ML

Stronger Baseline Models -- A Key Requirement for Aligning Machine Learning Research with Clinical Utility

Machine Learning (ML) research has increased substantially in recent years, due to the success of predictive modeling across diverse application domains. However, well-known barriers exist when attempting to deploy ML models in high-stakes, clinical settings, including lack of model transparency (or the inability to audit the inference process), large training data requirements with siloed data sources, and complicated metrics for measuring model utility. In this work, we show empirically that including stronger baseline models in healthcare ML evaluations has important downstream effects that aid practitioners in addressing these challenges. Through a series of case studies, we find that the common practice of omitting baselines or comparing against a weak baseline model (e.g. a linear model with no optimization) obscures the value of ML methods proposed in the research literature. Using these insights, we propose some best practices that will enable practitioners to more effectively study and deploy ML models in clinical settings.

cs.LG

PRISM: Patient Records Interpretation for Semantic Clinical Trial Matching using Large Language Models

Clinical trial matching is the task of identifying trials for which patients may be potentially eligible. Typically, this task is labor-intensive and requires detailed verification of patient electronic health records (EHRs) against the stringent inclusion and exclusion criteria of clinical trials. This process is manual, time-intensive, and challenging to scale up, resulting in many patients missing out on potential therapeutic options. Recent advancements in Large Language Models (LLMs) have made automating patient-trial matching possible, as shown in multiple concurrent research studies. However, the current approaches are confined to constrained, often synthetic datasets that do not adequately mirror the complexities encountered in real-world medical data. In this study, we present the first, end-to-end large-scale empirical evaluation of clinical trial matching using real-world EHRs. Our study showcases the capability of LLMs to accurately match patients with appropriate clinical trials. We perform experiments with proprietary LLMs, including GPT-4 and GPT-3.5, as well as our custom fine-tuned model called OncoLLM and show that OncoLLM, despite its significantly smaller size, not only outperforms GPT-3.5 but also matches the performance of qualified medical doctors. All experiments were carried out on real-world EHRs that include clinical notes and available clinical trials from a single cancer center in the United States.

cs.CL